Skin Diseases Treatment Industry Data Book Covers Acne, Actinic Keratosis, Atopic Dermatitis, Alopecia Markets.
The global skin diseases treatment industry combines to account for USD 88.25 billion in revenue in 2022, which is expected to reach USD 124.03 billion by 2030, growing at a cumulative rate of 4.3% over the forecast period.
Grand View Research’s skin diseases treatment industry data book is a collection of market sizing forecasts insights, regulatory technology framework, pricing intelligence, competitive benchmarking analyses, and macro-environmental analyses studies. Within the purview of the database, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research.
Actinic Keratosis Treatment Market Insights
The global actinic keratosis treatment market size was valued at USD 6.22 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 4.1% from 2022 to 2030.
Surgery held the largest revenue share of over 65.0% in 2021. The surgery segment is likely to maintain its dominance during the forecast period owing to higher penetration of cryotherapy for the treatment of actinic keratosis. However, the topical therapy segment is expected to maintain steady growth due to rising usage of self-usage therapy, growing home-based treatments, and various strategic initiatives are taken up by market players.
Nucleoside metabolic inhibitor held the largest share of over 30.0% in 2021. The growth of the nucleoside metabolic inhibitors is attributed to the strong commercial performance of Efudex, Carac, and fluroplex. Moreover, the increased awareness regarding actinic keratosis treatment and diagnosis has fueled the growth of the segment.
The hospitals segment held the largest share of over 25.0% in 2021. This is attributed to factors such as treatment rate accessibility, availability of healthcare facilities, and rising photodynamic therapy procedures performed in hospitals. There are several prescription medicines available that are used in performing photodynamic therapy.
Access the Global Skin Diseases Treatment Industry Data Book, 2022 to 2030, compiled with details like market sizing information forecasts, trade data, pricing intelligence, competition benchmarking, macro-environmental analyses, and regulatory technological framework studies
Alopecia Market Insights
The global alopecia market size was valued at USD 7.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.1% from 2021 to 2028.
The alopecia areata segment dominated the market and held the largest revenue share of 35.2% in 2020 driven by high disease prevalence and growing consumer awareness among patients. According to National Alopecia Areata Foundation, around 147.0 million people are affected by AA globally, out of this, around 6.8 million people live in the U.S. only.
The pharmaceutical segment dominated the market and accounted for the largest revenue share of more than 98.0% in 2020. The low cost of pharmaceutical products and high usage of prescription and OTC drugs are the main factors driving the segment. Finasteride and minoxidil are the most common drugs used to treat any form of alopecia.
The male alopecia segment dominated the market and accounted for the largest revenue share of 53.8% in 2020 owing to the high prevalence of hair loss in the male population worldwide. Androgenetic alopecia is the most common alopecia in the male population. It is estimated that approximately 50 percent of men experience some degree of hair loss at an average age of 50 with over 95% of cases being the androgenetic type.
The prescription segment dominated the market and accounted for the largest revenue share of 64.9% in 2020 due to the high number of visits to dermatologists for hair loss treatment. According to the National Library of Medicine, around 2.6 million outpatients visit dermatologists for alopecia areata treatment in the U.S. annually. Moreover, a strong product pipeline, growing disposable incomes, and rising prevalence of chronic diseases which ultimately lead to hair loss are expected to drive the segment growth at the fastest rate over the forecast period.
Acne Drugs Market Insights
The global acne drugs market size was valued at USD 4.1 billion in 2017 and is anticipated to register a CAGR of 4.2% during the forecast period.
Inflammatory acne is the largest segment by type. The condition occurs when pores are deeply clogged, resulting in swelling and redness. Bacterial infection may further aggravate this condition. Inflammatory acne captured more than 50.0% of the market in 2017, closely followed by comedonal type.
Retinoids and antibiotics remain the mainstay of the acne drug market. Retinoids dominated the therapeutic classes in 2017, closely followed by antibiotics. It is expected that retinoids will prevail as market leaders through 2025, driven by their first-line action and impending approval of pipeline products. Antibiotics are often administered in combination with benzoyl peroxide to prevent antibiotic resistance.
Topical therapies dominated the market in 2017 by route of administration. Retinoids, antibiotics, BPO, salicylic acid, and azelaic acid are administered topically for mild-to-moderate acne as well as maintenance therapy. Oral medications are recommended as systemic therapies after topical treatments fail to evoke a response.
U.S. held the largest revenue share among the seven major markets for acne treatment in 2017. It is expected that this regional market will witness steady growth over the coming years, retaining its lead through 2025. Growth will be collectively driven by lifestyle changes, rising disease incidence, and easy availability of products.
Key players operating in this market include Allergan, Bayer, Galderma, Stiefel, and Valeant. Valeant dominated the competitive landscape in 2017, by virtue of its wide array of anti-acne products. Valeant is likely to retain its lead in 2025 driven by strong sales of Retin-A Micro, Onexton, and Solodyn, as well as the launch of pipeline products.
Skin Diseases Treatment Market – Global Industry Segmentation
Skin Diseases Treatment Industry, By Indication
- Actinic Keratosis
- Atopic Dermatitis
- Alopecia
- Acne
Skin Diseases Treatment Industry, By End Use
- Hospitals
- Dermatology Clinics
- Home Care
- Others
Skin Diseases Treatment Industry, By Type
- Prescription
- OTC
Skin Diseases Treatment Industry, By Route of Administration
- Topical
- Injectable
- Oral
Actinic Keratosis Treatment Market, By Therapy
- Topical
- Photodynamic Therapy
- Surgery
Actinic Keratosis Treatment Market, By Drug Class
- Nucleoside Metabolic Inhibitor
- NSAIDs
- Immune Response Modifiers
- Photo Enhancers
- Others
Actinic Keratosis Treatment Market, By Drug Type
- Fluorouracil
- Imiquimod
- Diclofenac
- Others
Atopic Dermatitis Drugs Market, By Drug Class
- Corticosteroids
- Calcineurin Inhibitors
- Tacrolimus
- Pimecrolimus
- PDE-4 Inhibitors
- Biologics
- Others
Atopic Dermatitis Drugs Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Alopecia Market, By Disease Type
- Alopecia Areata
- Cicatricial Alopecia
- Traction Alopecia
- Alopecia Totalis
- Alopecia Universalis
- Androgenetic Alopecia
- Others
Alopecia Market, By Treatment
- Pharmaceuticals
- Devices
Alopecia Market, By Gender
- Male
- Female
Acne Drugs Market, By Product
- Retinoids
- Antibiotics
- Isotretinoin
- Others
Acne Drugs Market, By Age Group
- 9-20 years
- 21-40 years
- Above 41 years
Acne Drugs Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Order your copy of the Free Sample of “Skin Diseases Treatment Industry Data Book - Acne, Actinic Keratosis, Atopic Dermatitis, Alopecia Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research
Skin Diseases Treatment Industry Data Book Regional Outlook
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Denmark
- Norway
- Sweden
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Australia
- Thailand
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East Africa (MEA)
- South Africa
- United Arab Emirates
- Saudi Arabia
- Kuwait
- Rest of MEA
Skin Diseases Treatment Industry Data Book Competitive Landscape
The presence of well-established companies in the skin diseases treatment market makes the entry of smaller players with newer products difficult.
Key players operating in the skin diseases treatment industry are –
- Pfizer Inc.
- AbbVie Inc.
- Sun Pharmaceutical Industries Ltd.
- GSK plc.
- Amgen Inc.
- Eli Lilly and Company
- UCB
- Novartis AG
- Johnson Johnson
- Galderma S.A
- AstraZeneca plc
Go through the table of content of Skin Diseases Treatment Industry Data Book to get a better understanding of the Coverage Scope of the study
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com/sector-reports-list
